An Example of a Value-Added Chain Extending From Commodities Through Fine Chemicals to a Pharmaceutical Specialty Is Shown Inside the Book Titled Fine Chemicals: The Industry and the Business
Posted on: Monday, 16 April 2007, 09:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c54163) has announced the addition of Fine Chemicals: The Industry and the Business to their offering.
This book is a comprehensive reference on one of the most exciting and challenging segments of the modern chemical industry. It comprises descriptions of the leading fine chemical companies, the products, the markets and the technologies on a global basis. It serves also as a practical guide for developing and succeeding in the $ 60 billion fine chemicals business, which is usually lumped into the chemical or pharmaceutical industry.
About the Author
Peter Pollak, PhD, is a consultant for the fine chemicals industry. He worked for Lonza in Switzerland and the United States for more than thirty years, in positions including senior vice president and general manager of fine chemicals. He is internationally recognized as a pioneer in the development of the modern pharmaceutical fine chemicals industry.
Content Outline:
ACKNOWLEDGMENTS.
PREFACE.
PART I THE INDUSTRY.
1. What Fine Chemicals Are.
2. The Fine-Chemical Industry.
3. Products.
4. Technologies.
5. Facilities and Plants.
6. Research and Development.
7. Cost Calculation.
8. Management Aspects.
Bibliography.
PART II THE BUSINESS.
9. Market Size and Structure.
10. The Business Condition.
11. Customer Base.
12. Marketing.
Bibliography.
PART III OUTLOOK.
13. General Trends and Growth Drivers.
14. Globalization.
15. Biotechnology.
16. Ethical Pharmaceutical Industry/Custom Manufacturing.
17. Generics Industry/API-for-Generics.
18. Agro Fine Chemicals.
19. Contract Research Organizations.
20. Conclusion: Who Is Fittest for the Future?
Bibliography.
ABBREVIATIONS.
APPENDIX.
A.1 Information Sources/Life Sciences.
A.2 Checklist for New Product Evaluation.
A.3 Product Schedule, Custom Manufacturing Product.
A.4 Company Scorecard.
A.5 Job Description for Business Development Manager.
A.6 Selection Criteria for Outsourcing Partners.
A.7 Checklist for Customer Visit.
A.8 Outline for a Company Presentation.
A.9 Overseas Expansion of Indian Fine-Chemical Companies.
INDEX.
For more information visit http://www.researchandmarkets.com/reports/c54163
Source: Business Wire
Related Articles
- Cognizant Announces a Global Product Research and Development Relationship with Invensys Rail
- Cognizant Announces a Global Product Research and Development Relationship with Invensys Operations Management
- Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to Be Held in November
- MicroIslet Announces the Appointment of Amaresh Basu, Ph.D. As Vice President, Research and Development, and the Retention of Regulus Pharmaceutical Consulting
- Roche and Toyama Chemical Enter Licensing Agreement to Develop Potential Breakthrough Drug to Treat Rheumatoid Arthritis
- Skystar Bio-Pharmaceutical Signs Agreement With TNI-Penta for Research and Development of New Veterinary Drugs
- DFB Promotes Duncan Aust, Ph.D. To Senior Vice President of Research and Development, Branded Pharmaceuticals
- Landec Corporation and Air Products Announce Exclusive License and Research and Development Agreement
- Arena Pharmaceuticals' APD356 Selected As Winner of CONNECT's Most Innovative New Product Award in the Biotechnology Research and Development Category
- Emilio A. Emini, Ph.D., Appointed Executive Vice President, Vaccines Research and Development, Wyeth Pharmaceuticals
 |
 |
User Comments (0)
RSS Feeds